BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19620208)

  • 21. Ma2 antibodies: an evaluation of commercially available detection methods.
    Johannis W; Renno JH; Wielckens K; Voltz R
    Clin Lab; 2011; 57(5-6):321-6. PubMed ID: 21755821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demonstration of autoantibody binding to muscarinic acetylcholine receptors in the salivary gland in primary Sjögren's syndrome.
    Kovács L; Fehér E; Bodnár I; Marczinovits I; Nagy GM; Somos J; Boda V
    Clin Immunol; 2008 Aug; 128(2):269-76. PubMed ID: 18508410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies against GnRH and its receptor in patients with primary Sjögren's syndrome.
    Mandl T; Roth B; Ohlsson B
    Scand J Rheumatol; 2014; 43(4):338-48. PubMed ID: 24689972
    [No Abstract]   [Full Text] [Related]  

  • 24. Antimuscarinic antibodies in Sjögren's syndrome: where are we, and where are we going?
    Dawson L; Tobin A; Smith P; Gordon T
    Arthritis Rheum; 2005 Oct; 52(10):2984-95. PubMed ID: 16200578
    [No Abstract]   [Full Text] [Related]  

  • 25. Narcolepsy, REM sleep behavior disorder, and supranuclear gaze palsy associated with Ma1 and Ma2 antibodies and tonsillar carcinoma.
    Adams C; McKeon A; Silber MH; Kumar R
    Arch Neurol; 2011 Apr; 68(4):521-4. PubMed ID: 21482933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ICA69 autoantibodies in primary Sjögren's syndrome.
    Gordon TP; Cavill D; Neufing P; Zhang YJ; Pietropaolo M
    Lupus; 2004; 13(6):483-4. PubMed ID: 15303579
    [No Abstract]   [Full Text] [Related]  

  • 27. [Anti-PTH antibody and anti-calcitonin-antibody in Sjögren's syndrome].
    Yamauchi K; Fukase M; Isobe K; Fujita T
    Nihon Rinsho; 1983; 41(1):219-22. PubMed ID: 6842853
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibody to a high-prevalence blood group antigen Ata associated with Sjögren's syndrome.
    Mathur S; Sawhney H; Bertoni MA; Gupta R
    Ann Hematol; 2008 Jun; 87(6):497-8. PubMed ID: 18074134
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sjogren's syndrome. Study of the immune response].
    Andrada JA; Carchak MA; Comini E
    Medicina (B Aires); 1966; 26(2):91-7. PubMed ID: 5961181
    [No Abstract]   [Full Text] [Related]  

  • 30. Alpha-fodrin auto-antibody in Sjögren syndrome and other auto-immune diseases in childhood.
    Takahashi K; Tatsuzawa O; Yanagi K; Hayashi Y; Takahashi H
    Eur J Pediatr; 2001 Aug; 160(8):520-1. PubMed ID: 11548195
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-neuronal antibodies in Sjögren's syndrome and in paraneoplastic neurological disease.
    Moll JW; Markusse HM; Henzen-Logmans SC; Vecht CJ
    Lancet; 1994 May; 343(8908):1299. PubMed ID: 7910309
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-{alpha}-fodrin autoantibodies are not useful diagnostic markers of primary Sjögren's syndrome.
    Sordet C; Gottenberg JE; Goetz J; Bengoufa D; Humbel RL; Mariette X; Sibilia J
    Ann Rheum Dis; 2005 Aug; 64(8):1244-5. PubMed ID: 16014693
    [No Abstract]   [Full Text] [Related]  

  • 33. [Sjogren's syndrome: new etiopathogenetic findings].
    Meola MT; Serpico R
    Arch Stomatol (Napoli); 1980; 21(3):405-18. PubMed ID: 6960819
    [No Abstract]   [Full Text] [Related]  

  • 34. Incidence of thromboembolic events in patients with primary Sjögren's syndrome.
    Haga HJ; Jacobsen EM; Peen E
    Scand J Rheumatol; 2008; 37(2):127-9. PubMed ID: 18415770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurosarcoidosis with diencephalitis and anti-Ma2 antibodies.
    Desestret V; Didelot A; Meyronet D; Bruyas A; Jouvet A; Honnorat J
    Neurology; 2010 Mar; 74(9):772-4. PubMed ID: 20194918
    [No Abstract]   [Full Text] [Related]  

  • 36. Merkel cell carcinoma associated with a paraneoplastic neurological syndrome.
    Lopez MC; Pericay C; Agustí M; Martinez-Gallo M; Bordes R; Gelpí C
    Histopathology; 2004 Jun; 44(6):628-9. PubMed ID: 15186282
    [No Abstract]   [Full Text] [Related]  

  • 37. Low sensitivity of anti-alpha-fodrin antibodies in patients with primary Sjögren's syndrome.
    Bizzaro N; Villalta D; Tonutti E
    J Rheumatol; 2004 Nov; 31(11):2310-1; author reply 2311. PubMed ID: 15517652
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab.
    Ahmadi-Simab K; Lamprecht P; Nölle B; Ai M; Gross WL
    Ann Rheum Dis; 2005 Jul; 64(7):1087-8. PubMed ID: 15958765
    [No Abstract]   [Full Text] [Related]  

  • 39. Upbeat nystagmus in anti-Ma2 encephalitis.
    Garcia-Reitboeck P; Thompson G; Johns P; Al Wahab Y; Omer S; Griffin C
    Pract Neurol; 2014 Feb; 14(1):36-8. PubMed ID: 24043843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sjögren's syndrome.
    Locht H; Pelck R; Manthorpe R
    J Rheumatol; 2008 May; 35(5):845-9. PubMed ID: 18381788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.